| Name | (3R)-1'-Benzyl-3-phenyl-3,4'-bipiperidine-2,6-dione | 
|---|
| Description | Levetimide is a potent and stereoselective inhibitor of [3H](+)pentazocine binding, with a Ki of 2.2 nM[1]. | 
|---|---|
| Related Catalog | |
| In Vitro | Levetimide potently inhibits [3H]DTG binding although without stereoselectivity (Ki value of 103 nM) [1]. | 
| References | 
| Density | 1.178g/cm3 | 
|---|---|
| Boiling Point | 543.9ºC at 760mmHg | 
| Molecular Formula | C23H26N2O2 | 
| Molecular Weight | 362.46500 | 
| Flash Point | 282.7ºC | 
| Exact Mass | 362.19900 | 
| PSA | 52.90000 | 
| LogP | 3.48700 | 
| CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 | 
| HS Code | 2933399090 | 
|---|
| ~%   21888-99-3 | 
| Literature: JANSSEN PHARMACEUTICA N.V. Patent: WO2007/90826 A1, 2007 ; Location in patent: Page/Page column 65 ; WO 2007/090826 A1 | 
| HS Code | 2933399090 | 
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |